Healthcare and Pharmaceuticals

A Healthcare Good News Story

Following a tireless campaign by cancer patients, doctors and campaigners, the breast cancer drug Kadcyla has been re-listed on the UK’s Cancer Drug Fund (CDF) List and will remain available to terminal patients suffering with HER2-positive tumours for whom the medicine Herceptin no longer works. The pharmaceutical firm Roche’s Kadcyla drug is proven to prolong…

By using this website you agree to accept our Privacy Policy and Terms & Conditions